Quoted from http://www.bloomberg.com/news/2014-10-02/takeda-accused-in-trial-of-putting-actos-profits-ahead-of-safety.html
Takeda Accused of Putting Actos Profit Ahead of SafetyBy Jef Feeley Oct 2, 2014
Takeda Pharmaceutical Co. was accused by a lawyer for a woman who blames Actos for her cancer of sacrificing safety for profit by failing to warn patients and doctors about the diabetes medicine’s risks.
Executives at Osaka, Japan-based Takeda knew by 2004 that studies found links between Actos and cancer, and didn’t issue a warning until seven years later to protect billions of dollars in sales of the drug...
Wisniewski, a retired accountant who has bladder cancer, is the seventh Actos patient to take her suit to trial. Her case follows a $9 billion verdict this year in Louisiana against Takeda and Eli Lilly & Co. for hiding the diabetes medicine’s cancer risks. The companies have asked a judge to grant them a new trial in that case.
Takeda, Asia’s largest drugmaker, scrapped development of another diabetes drug this year when research linked it to liver damage. More than 3,500 Actos suits have been consolidated before U.S. District Judge Rebecca Doherty in Lafayette, Louisiana, for pretrial information exchanges, according to court dockets. The company faces another 4,500 cases in state courts in Illinois, West Virginia, California and Pennsylvania, according to court records.
In Wisniewski’s case, Takeda contends smoking rather than Actos is the most likely cause of the Norristown, Pennsylvania, resident’s bladder cancer. The 79-year-old Wisniewski “had many risk factors” for cancer other than the medicine, Craig Thompson, one of the drugmaker’s lawyers, told jurors in his closing arguments.